Abstract
The increased levels of c-Myc protein observed previously in an ovarian carcinoma cell line stably transfected to express HER2 has suggested a role for the HER2 pathway in c-Myc expression. Analysis of HER2-transfected cells stimulated with heregulin beta1 (HRG) revealed increased c-Myc protein levels but not a corresponding increase in c-Myc mRNA expression or any change in c-Myc protein half-life. Transfection of HER2-overexpressing cells with a construct containing the 5' untranslated region (5'UTR) of c-Myc mRNA originated from the P2 promoter and placed upstream of the Renilla luciferase gene, enhanced reporter expression upon stimulation with HRG. The HRG-mediated increase in reporter activity correlated with the HRG-mediated induction observed for c-Myc protein, identifying the P2-derived leader (P2L) of c-Myc mRNA as the cis-element involved in c-Myc translational induction. Both the increase in c-Myc protein levels and P2L-enhanced translational activity were inhibited by the PI3K inhibitor wortmannin. Together, these results demonstrate that HRG stimulation of HER2 overexpressing cells leads to enhanced c-Myc protein synthesis through activation of the PI3K/Akt/mTOR pathway and that the P2L of c-Myc mRNA is the element responsible for induction of c-Myc translation.
Copyright 2004 Wiley-Liss, Inc.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
5' Untranslated Regions / metabolism*
-
Androstadienes / pharmacology
-
Carcinoma / genetics
-
Carcinoma / metabolism
-
Carcinoma / pathology
-
Cell Line, Tumor
-
Clone Cells
-
Cycloheximide / pharmacology
-
Dactinomycin / pharmacology
-
Enzyme Inhibitors / pharmacology
-
Female
-
Gene Expression Regulation, Neoplastic / drug effects
-
Genes, Reporter
-
Genes, erbB-2
-
Genes, myc / drug effects*
-
Humans
-
Luciferases / metabolism
-
Neuregulin-1 / metabolism*
-
Neuregulin-1 / pharmacology
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / metabolism
-
Ovarian Neoplasms / pathology
-
Phosphatidylinositol 3-Kinases / metabolism
-
Promoter Regions, Genetic
-
Protein Biosynthesis* / drug effects
-
Protein Kinases / metabolism
-
Protein Serine-Threonine Kinases*
-
Protein Synthesis Inhibitors / pharmacology
-
Proto-Oncogene Proteins / metabolism
-
Proto-Oncogene Proteins c-akt
-
Proto-Oncogene Proteins c-myc / biosynthesis*
-
Proto-Oncogene Proteins c-myc / genetics
-
RNA, Messenger / genetics*
-
RNA, Messenger / metabolism
-
Signal Transduction
-
TOR Serine-Threonine Kinases
-
Wortmannin
Substances
-
5' Untranslated Regions
-
Androstadienes
-
Enzyme Inhibitors
-
Neuregulin-1
-
Protein Synthesis Inhibitors
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins c-myc
-
RNA, Messenger
-
heregulin beta1
-
Dactinomycin
-
Cycloheximide
-
Luciferases
-
Protein Kinases
-
MTOR protein, human
-
AKT1 protein, human
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins c-akt
-
TOR Serine-Threonine Kinases
-
Wortmannin